Alpa Laboratories Key Ratios
NSE: ALPA | BSE: 532878
₹50.38
As on 30-Oct-2026IST
Market cap
₹105 Cr
Revenue (TTM)
₹111 Cr
P/E Ratio
23.9
P/B Ratio
0.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -23.78 | 25.22 | 0.46 | 6.55 | -0.46 |
| EBIT | -238.45 | -3,525.58 | -235.67 | -183.97 | -189.36 |
| Net Profit | -29.07 | -91.66 | -83.31 | -34.51 | -12.54 |
| EPS | -29.13 | -91.67 | -83.31 | -34.53 | -12.54 |
| Book Value | -- | -- | 8.21 | 11.45 | 11.59 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 3.11 | 4.87 | -3.03 | 1.13 | 2.27 |
| Net Margin
| 13.46 | 12.81 | 3.64 | 12.35 | 14.36 |
| Return on equity
| 10.08 | 10.85 | 2.37 | 8.38 | 12.04 |
| Return on Capital
| 12.40 | 13.69 | -- | 9.39 | 15.73 |
| Return on Assets
| 8.15 | 8.60 | 1.88 | 6.45 | 9.61 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.01 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
9.39
|
15.73
|
14.31
|
12.19
|
|
Peer Median
|
--
|
19.41
|
21.76
|
21.89
|
--
|
ROE
2.37
Lower than Peers by 12.76
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
2.37
|
8.38
|
12.04
|
11.71
|
9.82
|
|
Peer Median
|
15.12
|
18.29
|
17.93
|
16.42
|
--
|
ROA
1.88
Lower than Peers by 8.20
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
1.88
|
6.45
|
9.61
|
9.60
|
7.80
|
|
Peer Median
|
10.09
|
9.88
|
12.81
|
12.32
|
--
|
EBIT Margin
-3.03
Lower than Peers by 21.53
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
-3.03
|
1.13
|
2.27
|
5.66
|
7.26
|
|
Peer Median
|
18.50
|
19.35
|
18.93
|
21.05
|
--
|
Net Margin
3.64
Lower than Peers by 10.71
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
3.64
|
12.35
|
14.36
|
13.57
|
12.30
|
|
Peer Median
|
14.35
|
13.32
|
14.94
|
15.51
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
16.16
|
19.30
|
17.23
|
14.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.46
Lower than Peers by 11.66
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
0.46
|
-5.91
|
3.41
|
16.98
|
-17.20
|
|
Peer Median
|
12.12
|
13.36
|
10.90
|
13.44
|
--
|
EBIT Growth
-235.67
Lower than Peers by 257.35
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
-235.67
|
-53.02
|
-58.53
|
-8.81
|
-25.08
|
|
Peer Median
|
21.69
|
18.45
|
15.01
|
23.50
|
--
|
Net Profit Growth
-83.31
Lower than Peers by 106.51
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
-83.31
|
-23.04
|
16.25
|
33.33
|
-10.71
|
|
Peer Median
|
23.20
|
18.73
|
14.80
|
30.12
|
--
|
EPS Growth
-83.31
Lower than Peers by 104.64
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
-83.31
|
-23.04
|
16.25
|
33.33
|
-10.71
|
|
Peer Median
|
21.33
|
14.40
|
14.27
|
29.02
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
8.21
|
13.32
|
12.88
|
10.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
0.01
|
0.00
|
0.03
|
0.02
|
|
Peer Median
|
0.01
|
0.05
|
0.06
|
0.03
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
0.01
|
0.00
|
0.03
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.01
Higher than Peers by 2.00
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
4.01
|
4.02
|
4.12
|
5.74
|
5.03
|
|
Peer Median
|
2.02
|
1.90
|
1.90
|
2.23
|
--
|
Quick Ratio
3.76
Higher than Peers by 2.27
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
3.76
|
3.76
|
3.74
|
5.25
|
4.61
|
|
Peer Median
|
1.49
|
1.45
|
1.46
|
1.59
|
--
|
Interest Coverage
19.47
Higher than Peers by 0.44
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
19.47
|
65.72
|
111.73
|
58.58
|
72.07
|
|
Peer Median
|
19.02
|
19.02
|
24.96
|
45.29
|
--
|
Operating Efficiency
Debtors to sales
36.91
Higher than Peers by 15.23
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
36.91
|
38.59
|
41.64
|
37.84
|
50.27
|
|
Peer Median
|
21.68
|
19.89
|
21.77
|
20.10
|
--
|
Asset Turnover
0.48
Lower than Peers by 0.23
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
0.48
|
0.45
|
0.55
|
0.62
|
0.58
|
|
Peer Median
|
0.71
|
0.74
|
0.76
|
0.81
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
151.19
|
142.78
|
147.50
|
166.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
53.42
|
50.81
|
44.15
|
55.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
100.34
|
79.22
|
71.98
|
99.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
104.27
|
114.37
|
119.67
|
122.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
23.93
Lower than Peers by 13.41
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
23.93
|
6.48
|
11.23
|
10.46
|
8.99
|
|
Peer Median
|
37.34
|
34.76
|
26.81
|
39.85
|
--
|
Price / Book Value
0.56
Lower than Peers by 4.25
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
0.56
|
0.52
|
1.27
|
1.16
|
0.84
|
|
Peer Median
|
4.81
|
4.93
|
4.65
|
6.11
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.52
|
0.52
|
0.61
|
0.37
|
--
|
EV/EBITDA
12.30
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
12.30
|
5.09
|
7.72
|
7.79
|
6.11
|
|
Peer Median
|
--
|
25.26
|
27.02
|
34.57
|
--
|
Market Cap
105
Lower than Peers by 17,567
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Alpa Laboratories
|
105
|
97
|
219
|
176
|
113
|
|
Peer Median
|
17,672
|
16,867
|
20,914
|
25,297
|
--
|